The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. CervoMed Inc shares valued at $18,160 were purchased by ELDER WILLIAM ROBERT on Aug 27 ’24. At $18.16 per share, ELDER WILLIAM ROBERT acquired 1,000 shares. The insider’s holdings grew to 1,267 shares worth approximately $7335.93 following the completion of this transaction.
As published in a research note from Chardan Capital Markets on March 13, 2025, CervoMed Inc [CRVO] has been rated up from a Neutral to a Buy and the price target has been revised to $14. Analysts at H.C. Wainwright downgraded the stock from ‘”a Buy”‘ to ‘”a Neutral”‘ outlook in a report released in mid December. As of December 11, 2024, Morgan Stanley has decreased its “an Overweight” rating to a “an Underweight” for CRVO. Earlier on December 11, 2024, Chardan Capital Markets downgraded its rating. Their new recommendation was “a Neutral” for CRVO stock which previously was a “a Buy”.
Analyzing CRVO Stock Performance
During the last five days, there has been a surge of approximately 169.30%. Over the course of the year, CervoMed Inc shares have jumped approximately 147.44%. Shares of the company reached a 52-week high of $7.97 on 03/13/25 and a 52-week low of $1.92 on 03/11/25. A 50-day SMA is recorded $2.38, while a 200-day SMA reached $10.95.
Support And Resistance Levels for CervoMed Inc (CRVO)
According to the 24-hour chart, there is a support level at 4.95, which, if violated, would cause prices to drop to 4.11. In the upper region, resistance lies at 7.30. The next price resistance is at 8.81. RSI (Relative Strength Index) is 83.90 on the 14-day chart, showing overbought technical sentiment. Moving Average Convergence Divergence (MACD) is at 2.03, which suggests the price will increase in the coming days. Percent R is at 36.03%, indicating low price movement. Stochastics %K at selling indicates that the stock is to be held.
